Neuroendoscopy Devices Market by Type (Rigid Neuroendoscope and Flexible Neuroendoscope), By Surgery (Intraventricular, Tranasnasal, and Transcranial), By Usability (Reusable Neuroendoscope and Disposable Neuroendoscope), By End-User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Report Overview

The Global Neuroendoscopy Devices Market Size is expected to be worth around US$ 326 Million by 2033, from US$ 197 Million in 2023, growing at a CAGR of 5.3% during the forecast period from 2024 to 2033.

Neuroendoscopy is a medical procedure of applying an endoscope to treatment on the condition of the central nervous system. Neuroendoscopy is existing being increasingly used in spine, brain, and skull-based pathologies in neurosurgery because of its improved visualization and better illumination. It has a wide variety of indications, such as hematoma evacuations, cranial cysts, infective conditions, rhinorrhea, and pituitary tumors.

Neuroendoscopy is a minimally surgical procedure where cancer is removed through small holes in the skull, mouth, or nose. Neuroendoscopy authorizes medical surgeons to approach problematic areas of the brain that are difficult to access in traditional surgeries. However, a Neuroendoscopy helps eliminate the tumor without harming or cutting another part of the skull.

Also, the increasing demand for minimally invasive procedures among the population is another growth factor that increases product demand. The neuro endoscopy market is currently at its developing stage of growth due to its complex growth. A neuro-endoscopic camera guided the brain with no minor effects.

Sometimes the camera arrives near the brain, and the doctor recognizes the medical issue to be treated. This device mainly treats pituitary tumors, intraventricular hemorrhage, hydrocephalus, and bleeding. As a result, the continuous increase in pituitary tumors and intraventricular hemorrhage is a dynamic growth factor. Neurosurgeons continuously attach the device to the different endoscopes with forceps and scissors.

Key Takeaways

• Market Growth: The global neuroendoscopy devices market is expected to grow at a CAGR of 5.3% from USD 197 million in 2022 to around USD 326 million by 2032.
• Procedure Advantages: Neuroendoscopy offers minimally invasive access to treat brain and spine conditions, reducing damage and improving visualization.
• Product Dominance: Rigid neuroendoscopes are prominent, benefitting from improved surgical outcomes.
• Flexible Adoption: Flexible neuroendoscopes are gaining traction due to their ability to access challenging areas.
• Surgery Trends: Transnasal neuroendoscopy is on the rise, commonly used for brain tumor removal.
• Usability Preference: Reusable neuroendoscopes lead the market due to cost-effectiveness.
• Key End-User: Hospitals are the primary users, driven by multispecialty hospitals and favorable health reimbursement policies.
• Growth Drivers: Rising brain tumor cases, technological advancements, and government support stimulate market growth.
• Challenges: Limited availability of neuroendoscopy professionals and high procedure costs restrain the market.
• Opportunities: Emerging economies, an aging population, and increased awareness offer growth prospects in the neuroendoscopy device market.

Type Analysis

Based on product type, the market of global neuro endoscopy devices is categorized into rigid neuro endoscopes and flexible neuro endoscopes. Due to the growth in demand for neuro endoscope procedures worldwide, the rigid neuro endoscope segment is anticipated to hold a significant neuro endoscopy device market share during the forecast period. A rigid endoscope comprises metal tubes containing light channels and lenses to diagnose.

This endoscope is incorporated with a series of high-resolution optical glass rod lenses for improved visualization of unavailable brain parts.  However, the rigid type is considered to be the oldest neuro endoscopy and is used in the predominance of surgical endoscopic applications.

Vendors of the rigid endoscope segment are focusing on improving their products to improve the surgical outcomes of invasive surgeries. The availability of a strict, improved system will increase the availability of fixed and semi-rigid endoscopes in hospitals and clinics and promote the growth of neuro endoscopy devices.

Moreover, the flexible neuro endoscope section is anticipated to witness significant growth during the forecast period. Increasing growth is expected because these endoscopes are incorporated with novel technology compared to rigid endoscopes. Flexible endoscopes will provide visibility of the internal side of the organ, which cannot be seen with necked eyes.

Surgery Analysis

Based on surgery analysis, the global neuro endoscope devices market is segmented into intraventricular, transnasal, and transcranial. Neuroendoscopic surgery for intraventricular brain tumors is one of the significant applications of neuroendoscopy. The transnasal neuroendoscopy is estimated to hold the dominat share of the market during the forecast period.

This advance is used in concordant CSF diversion, biopsy, non-communicating hydrocephalus treatment, and fibroid cyst removal. Transcranial Neuroendoscopy is used in diagnosing and treating larger tumors with the significant application of suprasellar extension. There are two types of endoscopic transcranial approaches like supraorbital and trans glabellar, which neurosurgeons widely use.

The transnasal method helps surgeons approach the anterior cranial base, clivus, para sellar region, and cranial vertebral junction in a low offensive manner compared to conventional neurosurgery techniques. Transnasal neuro endoscopy is recommended for the removal of cysts, biopsies, removal of pituitary gland tumors, and other obstructions. Transnasal neuro endoscopy sections witness positive growth trajectories due to the growing prevalence of brain tumors.

Usability Analysis

Based on usability, the neuroendoscopy market is divided into reusable neuroendoscope and disposable neuroendoscope . The reusable neuroendoscopes segments were considered the largest share of the market during the forecast period. This more significant share is mainly authorized to factors such as the cost-effectiveness of reusable approaches, as they can be used in several methods after acquisition.

The cost of a disposable neuroendoscope is lower than that of a reusable neuro endoscope. They are ultimately the infection problem as they are designed for single use. Disposable neuroendoscope can be used in the developing countries due to their lower cost.

End-User Analysis

Based on end-user, the market is sectioned into hospitals, ambulatory surgical centers, diagnostic centers, and others. Among these end-users, the hospital segment accounts for the majority of revenue share. In addition, the growth of multispecialty hospitals utilizing neuroendoscopic procedures and beneficial health reimbursement policies will significantly promote the development of the neuroendoscopy market in the hospital segment.

Also, increasingly expanding healthcare infrastructure in developing countries such as India, Mexico, and others are important for stimulating segmental growth. According to the study NCBI, there are presently approx. 50,000 neurosurgeons worldwide. The increase in the number of neurosurgeons is anticipated to increase the scope of the rising demand for neurosurgery. As a result, hospitals are essential revenue-generating centers.

Key Market Segments

Based on Type

• Rigid
• Flexible

Based on Surgery

• Intraventricular
• Transnasal
• Transcranial

Based on Usability

• Reusable
• Disposable

Based on End-User

• Hospitals
• Diagnostic Centre’s
• Ambulatory Surgical Centers
• Others

Drivers

Rising Incidence of Brain Tumors

One of the leading drivers for the global neuroendoscopic devices market is increasing demand for neuroendoscopy devices worldwide because of increasing technological advancements, one of the major factors supporting the market expansion. The market has grown because of the increased number of diseases such as optic nerve compression, brain tumor, osteosarcoma, and nervous system cyst.

Developments in imaging and fiber optics have the way for outstanding advancements in neuroendoscopy. Brain tumors are described by the growth of abnormal cells in the brain. Certain brain tumors are malignant simultaneously, while others are not. American Society of Clinical Oncology estimates several cases of brain tumors.

Increasing technological advancements and pertaining to neuroendoscopy devices coupled with rising the incidence of brain tumors are the key factors driving this market. Factors such as favorable government initiatives, increase in prevalence of neurological disorder and benefits of neuroendoscopic surgery over conventional brain surgery are driving the growth of this market.

Increasing Technological Advancements

Additionally, brain tumors account for 86% to 90% of all primary central nervous system tumors. Hence the expanding regularity of such illnesses will give growth opportunities for the neuroendoscopy device market; therefore, the mentioned factors will considerably encourage market growth during the forecast period.

However, the rising spreading neuro endoscope manufacturers coupled with the expanding number of isolated players appearing in the neuroendoscopy devices industry will more encourage market expansion. Technological advancement in the healthcare sector and increasing incidences of the of the pituitary tumors are driving the growth of these markets. Hence the aforementioned factor will significantly drive neuroendoscopy devices market growth.

Restraints

Limited Availability of Professionals Neuroendoscopy

In the developing nations, the limited availability of professionals in neuroendoscopy has limited the market growth during the forecast period. The increased cost of devices causes medical organization to choose conventional methods.

The growing availability of professional surgeries in medical sectors destination is one of the analytical neuroendoscopy devices market trends. High cost of neuroendoscopic procedures and instruments is the major restraint.

Opportunity

Growing Healthcare Market in Emerging Economy

Coincidently an increase in the prevalence of brain cancer will significantly impact the market of neuroendoscopy devices, providing opportunities in the neuroendoscopy device market. The global neuroendoscopy devices market is projected to grow during the forecast period due to increased brain tumor cases worldwide.

Radiation exposure, and a family history of brain tumors are risk factors. However, the aging population, which is prostate to a neurological disorder, is predicted to contribute to the global neuro endoscopic device market growth.

There is also growing awareness among the general public associability of effective treatment options for neurological treatments., thereby strengthening the market growth.  The advancement in neuro endoscopy technology can cause a shift in the neuro endoscopy device market trends. The new surgeries were found to have the highest success rate.

Regional Analysis

North America Dominates the Market Growth Owing to Its Rapid Expansion of Healthcare Technologies in the Region

The North America market share held the maximum revenue share of 38.5% during the forecast period and is anticipated to certify the largest market growth. Important companies such as  B Braun and Karl Storz are major key players in North America and are a substantial factor in regional development.

However, the growing regularity of acute pediatric brain tumors will further expand the market size in North America. North America’s market value is estimated to have the highest growth.

Technological promotion in the healthcare section increases incidences of pituitary tumors, granting the market growth. Asia Pacific market growth is anticipated to grow significantly regarding to the untapped growth opportunity in the region. Growing in the cases of brain tumors, along with the increase in medical facilities, drive strongly advise regional growth.

Glioblastoma is the furthermost common primary brain tumor among the elderly population; hence, a proliferation in population rate among countries such as India and China will allow significant device market share.

However, healthcare expenditure in developing countries such as India and others will further enhance the growth of the Asia Pacific neuroendoscopy market. In Europe neuro endoscopy, market share is anticipated to increase the predominance of market share across the region.

The presence of neurosurgeons in countries such as the UK, Germany, and France will further propel market growth. Moreover, the lack of awareness among the African and the Middle East population about minimally disturbing neurosurgical processes has led to a limited section in the region. Such benefits will significantly influence the neuroendoscopy device market growth over the forecast period.

Key Regions

• North America
  • The US
  • Canada
  • Mexico
• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America

• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

Market share analysis offers the analysis of traders’ contribution to the overall market. It provides an idea of its revenue generation into the general market compared to other traders; concerning neuro endoscopy devices market revenue, Aesculap, B. Braun, and Karl Storz are some of the leading major companies in the world.

The company holds a primary share in neuro endoscopy devices in the US. Major players in the market worldwide are Ackerman Instruments GmbH, Clarus Medical LLC, Adoer Medical AG, Olympus Corporation, Machida Endoscope, Tonglu WANHE Medical Instrument, Schindler Endoskopie Technologies GmbH, and others.

The neuro endoscopy device market is partial in nature, with multiple startups entering in recent years. The high cost of medical approaches causes medical institutions to prefer conventional methods, obstructing industry growth. The increasing rate of the Geriatric population across the globe is another factor donating to the neuro endoscopy market growth. Therefore, the factors mentioned above significantly drive neuro-endoscopic market growth.

Market Key Players

• Ackermann Instrument GmbH
• B Braun Meslsungen AG
• HAWK
• Clarus Medical LLC
• KARLSTORZSE & CO. AG
• Adeor Medical AG
• Nevro Corporation
• Tonglu WANHE Medical Instrument
• Machida Endoscope
• Schindler endoskopie Technology GmbH
• Olympus Corporation
• Boston Scientific Corporation
• Aesculap, Inc.
• KARL STORZ AE & CO
• Medical Instruments Co, Ltd.
• Evonos
• Other Key Players

Recent Developments

• In November 2023: Grant Funding, Hawk Biosystems received a $2.65 million grant to support its diagnostics platform, which is utilized in pathology samples for identifying post-translational modifications and protein-protein interactions. This funding supports Hawk’s efforts in providing alternative treatment decisions within oncology, inflammation, and immune disorders​.
• In February 2023: KARL STORZ established KARL STORZ VentureONE, a new subsidiary focused on developing robotic solutions for surgeries, including neuroendoscopy. This strategic expansion aims to combine artificial intelligence, virtual reality, and robotic technologies to enhance surgical procedures. The venture, with operations based in Singapore and Munich, reflects KARL STORZ’s commitment to pioneering advanced surgical ecosystems.

Report Scope